Skip to content

Depression: all studies

Page 1012 of 1,034: studies 10,111 to 10,120 of 10,336, newest first. Back to the depression overview

Research

Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.

Journal of Pharmacology and Experimental Therapeutics October 1, 1994

Tissue levels of serotonin (5-HT), levels of its metabolite 5-hydroxyindoleacetic acid (5-HIAA) and populations of 5-HT reuptake sites were measured in the brains of rats exposed to 3,4-methylenedioxymethamphetamine (MDMA) at selected developmental ages. MDMA exposure at postnatal day (PND) 10 did not result in altered 5-HT or 5-HIAA levels 1 week after administration in any brain region...

Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo.

Neuroscience September 1994 S R White, P Duffy, P W Kalivas

The nucleus accumbens has been implicated as an important site for the actions of many drugs that are used recreationally. This study examined the effects of methylenedioxymethamphetamine (MDMA), a euphoric and hallucinogenic drug, on glutamate-evoked neuronal firing and on extracellular levels of dopamine and serotonin in the nucleus accumbens of the rat. Microiontophoretic application of MDMA...

Cannabis Amotivational Syndrome and Personality Trait Absorption: A Review and Reconceptualization

Imagination, Cognition and Personality September 1, 1994 Peter L. Nelson

This article argues that the so-called cannabis “amotivation syndrome,” widely reported in the literature, may not be a single nosological entity, but represent, instead, a change in cognitive style emerging as a result of cannabis's ability to facilitate a unique attentional state favoured by those who have a higher than average level of a personality factor referred to as “trait absorption.”...

Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)

The British Journal of Psychiatry September 1, 1994 Philip Mcguire, Helen Cope, Thomas Fahy 187 citations

Background 3,4-methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) has become one of the most widely used illicit substances in the UK. Little is known of the psychiatric morbidity which may be associated with its use. We have examined this association by collecting a series of psychiatric cases in which MDMA use was a prominent feature. Method Patients presenting between 1990 and 1992 with...

DOI: 10.1192/bjp.165.3.391 (opens in new tab) Ecstasy Psychopathology Diversity politics

The excitability and rhythm of medullary respiratory neurons in the cat are altered by the serotonin receptor agonist 5-methoxy-N,N, dimethyltryptamine.

Brain Research June 13, 1994 P M Lalley 37 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeODMT) is an indolealkylamine which has agonist activity at 5HT receptors. In the present investigation, 5-MeODMT had two types of effects on medullary respiratory neurons of the cat. Iontophoretic administration or i.v. doses (43 +/- 8.9 micrograms/kg) of 5-MeODMT hyperpolarized respiratory neurons and severely reduced action potential discharges....

Some Effects of Group Drug Taking

Perspectives in biology and medicine March 1, 1994 Erwin Di Cyan

SOME EFFECTS OF GROUP DRUG TAKING ERWIN DI CYAN* The purpose of this paper is to discuss briefly some aspects of the differences between drug effects when drugs are used in groups as distinguished from their solitary use. The human organism responds to a variety of stimuli. Its response to signals may be physiological or psychological. The latter response includes recollections by (a) retrieval...

Psychiatric complications of 'Ecstasy' use

Journal of Psychopharmacology 1994 Hugh Series, Sietske Boeles, Eluned Dorkins et al. 44 citations

Two case reports are presented of significant psychiatric disorders associated with ingestion of 'Ecstasy' (3,4-methylenedioxymethamphetamine), a recreational drug whose use appears to be increasing. In one case, the patient developed a brief paranoid psychosis which recurred and persisted for at least a month after he took a second dose of the drug. In the other, the patient experienced...

Spirit possession and healing among Chinese psychiatric patients.

Acta Psychiatrica Scandinavica December 1, 1993 E H Kua, P H Chew, S M Ko 48 citations

This is a study of the illness behaviour of 100 Chinese psychiatric patients referred consecutively to the psychiatric unit of a general hospital in Singapore. More women than men felt that their illness was due to spirit possession; but belief in possession was not related to educational status. Thirty-six patients or their relatives had consulted a traditional healer before going to the...

Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat.

Pharmacology, Biochemistry, and Behavior October 1993 U Liminga, A E Johnson, P E Andrén et al.

Bilateral infusion of 5-hydroxytryptamine (5-HT) agonists into the substantia nigra pars reticulata (SNr) of awake rats was shown to influence oral behavior. The 5-HT1A agonist (R)-8-hydroxy-2-(di-propylamino)- tetralin (8-OH-DPAT) (1.3-13 nmol on each side) produced a dose-dependent depression of vacuous chewing movements (VCMs) that lasted about 20 min. The (R)-8-OH-DPAT-induced depression of...

Use of Qat in the UK

Psychiatric Bulletin December 1, 1992 Stefan Cembrowicz

Use ofQat in the UKDEARSIRS A recent newspaper article (The Independent, 1992) suggested that the plight of some Somalian refugees in this country is compounded by the adverse effects of heavy use of Qat, a mood-altering plant.Last year I encountered an acute psychotic episode associated with the use of Qat.My patient, a 28-year old Somalian male student, was brought to me by friends concerned...